Clinical Trial Update: Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

This document reports on a pilot open-label Phase 2 clinical trial evaluating abatacept in patients with ankylosing spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Ankylosing Spondylitis | Phase 2 | Status: UNKNOWN